Do BRCA1 mutations affect the ability to breast-feed? Significantly shorter length of breast-feeding among BRCA1 mutation carriers compared with their unaffected relatives

Breast

Volumn 7, Issue 6, 1998, Pages 320-324

  Jernstrom H ^a   Johannsson, O ^a   Borg, A ^a   Olsson, H ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST FEEDING; CANCER GENETICS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; MATERNAL AGE; MILK PRODUCTION; ONCOGENE; PRIORITY JOURNAL; RELATIVE; SMOKING; STATISTICAL ANALYSIS;

EID: 0032456403     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(98)90074-1     Document Type: Article

References (21)

1. Hall J M, Lee M K, Newman B et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250(4988): 1684-1689.
2. Narod S A, Feunteun J, Lynch H T et al. Familial breast-ovarian cancer locus on chromosome 17q21-q23. Lancet 1991; 338(8759): 82-83.
3. Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266(5182): 66-71.
4. Shattuck-Eidens D, McClure M, Simard J et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 1995; 273(7): 535-541.
5. Wooster R, Neuhausen S L, Mangion J et al. Localization of breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265(5181): 2088-2090.
6. Gowen L C, Johnson B L, Latour A M, Sulik K K, Koller B H. BRCA1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet 1996; 12(2): 191-194.
7. Dickson R. Biochemical Control of Breast Development. In: Harris J R, Lippman M E, Morrow M, Hellman S, eds. Diseases of the Breast. Philadelphia: Lippincott-Raven, 1996: 15-25.
8. Russo J, Tay L, Russo I. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Research and Treatment 1982: 2(1): 5-73.
9. Håkansson S, Johannsson O, Johansson U et al. Moderate frequency of BRCA1 and BRCA2 germline mutations in Scandinavian familial breast cancer. Am J Hum Genet 1997; 60(5): 1068-1078.
10. Johannsson O, Ostermeyer E, Håkansson S et al. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am J Hum Genet 1995; 58: 441-450.
11. Scully R, Chen J, Plug A et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 1997; 88(Jan 24): 265-275.
12. Marquis S T, Rajan J V, Wynshaw-Boris A et al. The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 1995; 11(1): 17-26.
13. Marks J R, Huper G, Vaughn J P et al. BRCA1 expression is not directly responsive to estrogen. Oncogene 1997; 14(1): 115-121.
14. Donehower L A, Harvey M, Slagle B L et al. Mice deficient for pS3 are developmentally normal but show susceptibility to spontaneous tumours. Nature 1992; 356(6366): 215-221.
15. Jacks T, Fazeli A, Schmitt E M, Bronson R T, Goodell M A, Weinberg R A. Effects of an Rb mutation in the mouse. Nature 1992; 359(6393): 295-300.
16. Clarke A R, Maandag E R, van Roon M et al. Requirement of a functional Rb-1 gene in murine development. Nature 1992; 359(6393): 328-330.
17. Hopkinson J, Schanler R, Franley J, Garza C. Milk production by mothers of premature infants: influence of cigarette smoking. Pediatrics 1992; 90(6): 934-938.
18. Vio F, Salazar G, Infante C. Smoking during pregnancy and lactation and its effect on breast-milk volume. Am J Clin Nutr 1991; 54(6): 1011-1016.
19. Stahlberg M. Breast feeding and social factors. Acta Paediatr Scand 1985; 74(1): 36-39.
20. Freysteinsson H, Sigurdsson J A. Breast-feeding in Iceland. Predicative factors and effects of interventive measures. Scan J Soc Med 1996; 24(1): 62-66.
21. Jernström H, Olsson H. Breast size in relation to endogenous hormone levels, body constitution, and oral contraceptive use in healthy nulligravid women aged 19-25 years. Am J Epidemiol 1997; 145(7): 571-580.